Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea. See safety info including Boxed Warning.

Deutetrabenazine, sold under the brand name Austedo, is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's disease and tardive …

Jun 26, 2024 · Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Austedo is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington's disease.

Jan 29, 2025 · Austedo (deutetrabenazine) is a brand-name prescription drug that’s used for certain movement disorders. Learn about side effects, warnings, dosage, and more.

Feb 28, 2025 · AUSTEDO XR extended-release tablets and AUSTEDO tablets are formulated with deutetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor for oral administration.

The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. Adverse reactions …

AUSTEDO XR and AUSTEDO can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Anyone considering the use of AUSTEDO XR or …

Sep 21, 2025 · AUSTEDO XR and AUSTEDO should be avoided in patients with congenital long QT syndrome and in patients with a history of cardiac arrhythmias.